Wearable ECG to screen for atrial fibrillation and assess stroke risk
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests if a wearable ECG device can help detect atrial fibrillation (AF), an irregular heartbeat that can raise stroke risk, in people at higher risk for stroke. You would wear the device for a while to see if it picks up signs of AF that need treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 40 or older.
- Classified as high-risk for stroke based on the '8+2' stroke screening score.
- Able to use the wearable device on your own or with help from a family member.
- Willing to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new wearable device that tracks your heart's electrical activity. It is designed to see if it works as well as a standard ECG machine.
This trial tests a wearable heart monitor (Skiin garment) to catch any return of atrial fibrillation after you've had a procedure (catheter ablation). If you're scheduled for this procedure and can wear the monitor for about 7 months, you may help improve detection of irregular heartbeats.
This study tests whether a small adhesive heart-monitoring patch can detect atrial fibrillation (an irregular heartbeat) in people 60 and older who have never been diagnosed with it. Finding atrial fibrillation early may help prevent serious complications like stroke.
This study tests if using a digital device (like a smartwatch or phone) can help find an irregular heartbeat called atrial fibrillation. Finding it early may help prevent stroke, especially in people over 65.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This trial tests if a smartwatch can accurately measure how often atrial fibrillation (irregular heartbeat) occurs. If you have AFib and can wear a watch, you may help doctors find a simpler way to track your condition.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.